4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide

C30H40N8O2 — CID 11249762

IUPAC4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide
SMILESCCCOc1ccc2c(c1)nc(N(Cc1ccc(C(=O)Nc3nn[nH]n3)cc1)C1CCC(C(C)(C)C)CC1)n2C
InChIInChI=1S/C30H40N8O2/c1-6-17-40-24-15-16-26-25(18-24)31-29(37(26)5)38(23-13-11-22(12-14-23)30(2,3)4)19-20-7-9-21(10-8-20)27(39)32-28-33-35-36-34-28/h7-10,15-16,18,22-23H,6,11-14,17,19H2,1-5H3,(H2,32,33,34,35,36,39)
InChIKeyXZWARNFFTTZXAA-UHFFFAOYSA-N
MW544.70 g/mol
LogP5.74
Rot. Bonds9

About 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide

4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide (PubChem CID 11249762) has the molecular formula C30H40N8O2 and a molecular weight of 544.70 g/mol. Its IUPAC name is 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide.

Molecular Properties

Compound Name4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide
PubChem CID11249762
Molecular FormulaC30H40N8O2
Molecular Weight544.70 g/mol
Exact Mass544.33
IUPAC Name4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide
SMILESCCCOc1ccc2c(c1)nc(N(Cc1ccc(C(=O)Nc3nn[nH]n3)cc1)C1CCC(C(C)(C)C)CC1)n2C
InChIInChI=1S/C30H40N8O2/c1-6-17-40-24-15-16-26-25(18-24)31-29(37(26)5)38(23-13-11-22(12-14-23)30(2,3)4)19-20-7-9-21(10-8-20)27(39)32-28-33-35-36-34-28/h7-10,15-16,18,22-23H,6,11-14,17,19H2,1-5H3,(H2,32,33,34,35,36,39)
InChIKeyXZWARNFFTTZXAA-UHFFFAOYSA-N
XLogP5.74
TPSA113.85 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms40
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500544.70
LogP ≤ 55.74
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The IUPAC name of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide (CID 11249762) is 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide.
What is the SMILES notation for 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The canonical SMILES for 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide is CCCOc1ccc2c(c1)nc(N(Cc1ccc(C(=O)Nc3nn[nH]n3)cc1)C1CCC(C(C)(C)C)CC1)n2C.
What is the InChIKey of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
The InChIKey is XZWARNFFTTZXAA-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H40N8O2/c1-6-17-40-24-15-16-26-25(18-24)31-29(37(26)5)38(23-13-11-22(12-14-23)30(2,3)4)19-20-7-9-21(10-8-20)27(39)32-28-33-35-36-34-28/h7-10,15-16,18,22-23H,6,11-14,17,19H2,1-5H3,(H2,32,33,34,35,36,39).
What are the key properties of 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide?
4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide has a molecular weight of 544.70 g/mol, XLogP of 5.74, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[(4-tert-butylcyclohexyl)-(1-methyl-5-propoxybenzimidazol-2-yl)amino]methyl]-N-(2H-tetrazol-5-yl)benzamide is sourced from PubChem (CID 11249762), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).